|
Index of reports
> Disability (3)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Kenalog-40 (Triamcinolone) disability. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Kenalog-40 side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-20
Patient: female, weighing 53.5 kg (117.8 pounds)
Reactions: Confusional State, Arthralgia, Injection Site Atrophy, Gait Disturbance, Joint Injury, Frustration, Fall, Joint Stiffness
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Kenalog-40
Possible Kenalog-40 side effects in 38 year old female
Reported by a consumer/non-health professional from United States on 2011-12-06
Patient: 38 year old female
Reactions: Product Quality Issue, Peripheral Coldness, Paraesthesia, Injection Site Erythema, Dysstasia, Injection Site Reaction, Lipoatrophy, Walking Disability
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Xylocaine
Dosage: 3.1 ratio with dexamethasone, intradermal)
Indication: Injection
Start date: 2009-11-18
Kenalog-40
Dosage: intradermal
Indication: Injection
Start date: 2009-11-18
Dexamethasone Sodium Phosphate
Dosage: 3.1 ratio with 2.0 cc 1`% xylocaine, intradermal
Indication: Steroid Therapy
Start date: 2009-11-18
Possible Kenalog-40 side effects in 65 year old male
Reported by a consumer/non-health professional from United States on 2011-10-04
Patient: 65 year old male, weighing 70.0 kg (154.0 pounds)
Reactions: Vomiting, Pneumonia, Dystonia, Sensation of Heaviness, Ataxia, Fall, Speech Disorder, Oedema Peripheral, Vision Blurred, Dizziness, Hallucination, Hypertension
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Kenalog-40
Other drugs received by patient: Lidocaine
|
